Stanford Advisors


All Publications


  • Transient Activation of the Interferon-Stimulated Gene Program Drives Persistent Smooth Muscle Cell Reprogramming and Alters Cell Fate in Atherosclerosis Rad, L., Monteiro, J. P., Worssam, M., Li, D., Gu, W., Nguyen, T., Kundu, R. K., Kim, J. B., Cheng, P., Quertermous, T., Weldy, C. LIPPINCOTT WILLIAMS & WILKINS. 2026: A10656
  • An Atlas-Scale, Gene-Program Guided Framework for Functional Translation of Coronary Artery Disease Mechanisms Karius, A., Worssam, M., Monteiro, J. P., Yu, A., Boluk, A., Cheng, P., Amrute, J., Kaikkonen, M. U., Quertermous, T., Li, D. LIPPINCOTT WILLIAMS & WILKINS. 2026: A11459
  • Polyethylene and Polyvinyl Chloride Nanoplastics Accelerate Atherosclerosis Through Distinct Smooth Muscle Cell Phenotypic Transitions. medRxiv : the preprint server for health sciences Zheng, S., Gu, W., Zhao, Q., Kojima, Y., Palm, K. C., Mokry, M., Jarr, K. U., Gao, H., Damiani, I., Qin, G., Bahia, G., Basu, S., Kundu, R., Worssam, M., Monteiro, J. P., Berezowitz, A., Weldy, C. S., Cheng, P., Pasterkamp, G., Leeper, N. J., Kim, J. B. 2026

    Abstract

    Micro- and nanoplastics (MNPs) are increasingly detected in human tissues, yet their causal contribution to cardiovascular disease remains poorly understood. Here we show that oral exposure to polyethylene (PE) and polyvinyl chloride (PVC) -- the most abundant polymers found in human atheromas -- accelerates atherosclerosis in ApoE-/- mice through distinct, polymer-specific molecular mechanisms. While both polymers increased plaque burden and reduced contractile smooth muscle cell (SMC) markers, single-cell transcriptomic profiling revealed divergent phenotypic trajectories. PE exposure drives SMCs toward a chondromyocyte-like cell (CMC) state, characterized by upregulated osteogenic signaling and markedly increased vascular calcification. Conversely, PVC exposure promotes a fibromyocyte-like program associated with altered collagen metabolism and accelerated cell migration without enhancing calcification. These distinct SMC programs are reflected in the transcriptional signatures of symptomatic human carotid plaques, suggesting clinical relevance for polymer-specific vascular remodeling. Our findings establish a causal link between common environmental plastics and accelerated atherosclerosis, demonstrating that MNP-induced vascular risk is mediated by divergent SMC fate decisions. These results provide a mechanistic framework for assessing the cardiovascular impact of global plastic pollution and identifying potential therapeutic targets to mitigate MNP-associated vascular toxicity.

    View details for DOI 10.64898/2026.02.10.26345390

    View details for PubMedID 42282188

    View details for PubMedCentralID PMC13252418

  • Transcriptomic, Specific Marker, and Pathway Analysis of Smooth Muscle Cell Foam Cells Compared to Macrophage Foam Cells in Human Atherosclerosis. bioRxiv : the preprint server for biology Allahverdian, S., Mao, Y., Xiang, P., Blanchard, V., Bölük, A., Hart, P. A., Cheng, P., Li, D. Y., Worssam, M. D., Arasu, U. T., Taipale, M., Kiema, M., Laakkonen, J. P., Örd, T., Kaikkonen, M. U., Miller, C. L., Quertermous, T., Chan, T., Francis, G. A. 2026

    Abstract

    Smooth muscle cells (SMCs) comprise the majority of cells in atherosclerotic lesions and are thought to be a major source of cholesterol-overloaded foam cells in human and mouse atheromas. However, the transcriptomic profile, specific markers, and biologic itinerary of SMC foam cells relative to macrophage foam cells remain poorly defined.Single-cell RNA sequencing (scRNA-seq) was performed on fresh coronary segments from heart transplant recipients with early- to intermediate-stage atherosclerosis. Gene expression in a putative SMC foam cell cluster was compared with cultured SMCs loaded with aggregated low-density lipoprotein (agLDL) or cholesterol-methyl-β-cyclodextrin (Chol-MβCD). Candidate markers distinguishing SMC from macrophage foam cells were validated using additional publicly-available scRNA-seq datasets, Xenium spatial transcriptomics, and immunofluorescence microscopy of human coronary atheromas. Pathway analysis was performed using Gene Set Enrichment Analysis Hallmark gene sets.A distinct SMC foam cell cluster derived from fibromyocytes ("lipomyocytes") was identified using markers induced by in vitro cholesterol loading. agLDL loading reproduced the lipomyocyte transcriptional profile, whereas Chol-MβCD induced an inflammatory phenotype colocalizing with macrophages rather than lipomyocytes. Lipomyocytes highly expressed SERPINE1, encoding plasminogen activator inhibitor-1 (PAI-1), and CFH, encoding complement factor H, which were validated in human coronary lesions by spatial transcriptomics and immunofluorescence microscopy. Compared with macrophage foam cells, lipomyocytes demonstrated distinct pathway activation, including enrichment of extracellular matrix, coagulation and angiogenesis pathways.SMC foam cells, or lipomyocytes, represent a distinct foam cell phenotype with unique markers and biologic programs that differ from macrophage foam cells during atherosclerotic plaque development.

    View details for DOI 10.64898/2026.05.27.728334

    View details for PubMedID 42282821

    View details for PubMedCentralID PMC13252066

  • Vascular smooth muscle cell state trajectories mediate molecular mechanisms of coronary disease risk. Nature communications Li, D. Y., Kundu, S., Cheng, P., Gu, W., Worssam, M. D., Jackson, W. R., Zhao, Q., Nguyen, T., Yu, A. M., Monteiro, J. P., Caceres, R. D., Dale, S., Palmisano, B. T., Weldy, C. S., Ramste, M., Kundu, R., Kundaje, A., Wirka, R. C., Quertermous, T. 2026

    Abstract

    Vascular smooth muscle cells contribute to heritable coronary artery disease risk and undergo complex transitions to multiple disease-related phenotypes. To investigate the genetic basis of these trajectories, we develop a dense timecourse single-cell transcriptomic and epigenetic map of atherosclerosis in a murine disease model accompanied by high-plex in situ spatial data. Using temporal data and probabilistic fate modeling, we identify key transcription factors that drive cell state changes through a combination of network-based prioritization and in silico transcription factor perturbation. Parallel knockout studies of validated coronary artery disease gene Tcf21 uncover its molecular mechanisms in smooth muscle cell transition, due in part to a role regulating the transition of smooth muscle cells in the secondary heart field. Integrating the murine atlas with human coronary artery disease genetics pinpoint smooth muscle cell phenotypes that mediate disease risk, highlighting causal disease mechanisms. Together, these studies resolve atherosclerosis trajectories at single-cell resolution and identify genetic causal transcriptomic and epigenomic mechanisms of coronary artery disease risk.

    View details for DOI 10.1038/s41467-026-70530-z

    View details for PubMedID 41844614

  • Vascular smooth muscle cell atherosclerosis trajectories characterized at single cell resolution identify causal transcriptomic and epigenomic mechanisms of disease risk Li, D., Kundu, S., Cheng, P., Gu, W., Jackson, W., Zhao, Q., Nguyen, T., Worssam, M., Monteiro, J., Palmisano, B., Weldy, C., Kundu, R., Kundaje, A., Wirka, R., Quertermous, T. LIPPINCOTT WILLIAMS & WILKINS. 2025
  • Chronic Electronic Cigarette Exposure Promotes Atherosclerosis and Chondrogenic Modulation of Smooth Muscle Cells Damiani, I., Weldy, C., Zhao, Q., Hurtado Solberg, E., Qin, G., Easwaran, M., Basu, S., Gu, W., Worssam, M., Monteiro, J., Zheng, S., Kaur Bahia, G., Kundu, R., Nguyen, T., Direnzo, E., Cheng, P., Kim, J. LIPPINCOTT WILLIAMS & WILKINS. 2025
  • The epigenomic landscape of single vascular cells reflects developmental origin and identifies disease risk loci Weldy, C., Kundu, S., Monteiro, J., Gu, W., Pedroza, A., Dalal, A., Worssam, M., Li, D., Palmisano, B., Zhao, Q., Sharma, D., Nguyen, T., Kundu, R., Fischbein, M., Engreitz, J., Kundaje, A., Cheng, P., Quertermous, T. LIPPINCOTT WILLIAMS & WILKINS. 2025
  • A cell and transcriptome atlas of human arterial vasculature. Cell genomics Zhao, Q., Pedroza, A., Sharma, D., Gu, W., Dalal, A., Weldy, C., Jackson, W., Li, D. Y., Ryan, Y., Nguyen, T., Shad, R., Palmisano, B. T., Monteiro, J. P., Worssam, M., Berezwitz, A., Iyer, M., Shi, H., Kundu, R., Limbu, L., Kim, J. B., Kundaje, A., Fischbein, M., Wirka, R., Quertermous, T., Cheng, P. 2025: 101034

    Abstract

    Arterial segments show differing disease propensities, yet mechanisms remain unknown. We compiled a transcriptomic and spatial atlas of healthy human arterial cells across multiple segments to understand these differences. Arteries demonstrated a stereotyped pattern of cell-specific, segmental heterogeneity not captured by common marker genes. Arterial identities are encoded in fibroblast and smooth muscle cell (SMC) transcriptomes. Differentially expressed genes enrich for disease loci. Fibroblast gene expression enriches for a disproportionate number of disease loci, highlighting an underrecognized role for fibroblasts in disease risk. Cells of different segments cluster more by embryonic origin than anatomy. Global analysis of disease regulons in fibroblasts and SMCs identified developmental transcription factors that persist into adulthood, suggesting a functional role of these factors in disease. Lastly, the heterogeneity of non-coding transcriptomes rivals that of protein-coding transcriptomes. Differentially expressed lncRNAs enrich for genetic signals for vascular diseases, suggesting a role for lncRNAs in vascular disease.

    View details for DOI 10.1016/j.xgen.2025.101034

    View details for PubMedID 41086809

  • Smooth muscle expression of RNA editing enzyme ADAR1 controls activation of the RNA sensor MDA5 in atherosclerosis. Nature cardiovascular research Weldy, C. S., Li, Q., Monteiro, J. P., Peters, T. S., Guo, H., Galls, D., Gu, W., Cheng, P. P., Ramste, M., Li, D., Palmisano, B. T., Sharma, D., Worssam, M. D., Zhao, Q., Bhate, A., Kundu, R. K., Nguyen, T., Mokry, M., Miller, C. L., van der Laan, S. W., Li, J. B., Quertermous, T. 2025

    Abstract

    Although genetic risk in coronary artery disease (CAD) is linked to changes in gene expression, recent discoveries have revealed a major role for A-to-I RNA editing in CAD. ADAR1 edits immunogenic double-stranded RNA (dsRNA), preventing activation of the dsRNA sensor MDA5 (IFIH1) and downstream interferon-stimulated gene signaling. Using human plaque analysis and human coronary artery smooth muscle cells (SMCs), here, we show that SMCs uniquely require RNA editing and that MDA5 activation regulates SMC phenotype. In a conditional SMC-specific Adar deletion mouse model on an atherosclerosis-prone background, combined with Ifih1 deletion and single-cell RNA sequencing, we demonstrate that ADAR1 preserves vascular integrity and limits atherosclerosis and calcification by suppressing MDA5 activation. Analysis of the Athero-Express carotid endarterectomy cohort further shows that interferon-stimulated gene expression correlates with SMC modulation, plaque instability and calcification. These findings reveal a fundamental mechanism of CAD, where cell type and context-specific RNA editing modulates genetic risk and vascular disease progression.

    View details for DOI 10.1038/s44161-025-00710-5

    View details for PubMedID 40958051

    View details for PubMedCentralID 4589895

  • Epigenomic landscape of single vascular cells reflects developmental origin and disease risk loci. Molecular systems biology Weldy, C. S., Kundu, S., Monteiro, J., Gu, W., Pedroza, A. J., Dalal, A. R., Worssam, M. D., Li, D., Palmisano, B., Zhao, Q., Sharma, D., Nguyen, T., Kundu, R., Fischbein, M. P., Engreitz, J., Kundaje, A. B., Cheng, P. P., Quertermous, T. 2025

    Abstract

    Vascular sites have distinct susceptibility to atherosclerosis and aneurysm, yet the epigenomic and transcriptomic underpinning of vascular site-specific disease risk is largely unknown. Here, we performed single-cell chromatin accessibility (scATACseq) and gene expression profiling (scRNAseq) of mouse vascular tissue from three vascular sites. Through interrogation of epigenomic enhancers and gene regulatory networks, we discovered key regulatory enhancers to not only be cell type, but vascular site-specific. We identified epigenetic markers of embryonic origin including developmental transcription factors such as Tbx20, Hand2, Gata4, and Hoxb family members and discovered transcription factor motif accessibility to be vascular site-specific for smooth muscle, fibroblasts, and endothelial cells. We further integrated genome-wide association data for aortic dimension, and using a deep learning model to predict variant effect on chromatin accessibility, ChromBPNet, we predicted variant effects across cell type and vascular site of origin, revealing genomic regions enriched for specific TF motif footprints-including MEF2A, SMAD3, and HAND2. This work supports a paradigm that cell type and vascular site-specific enhancers govern complex genetic drivers of disease risk.

    View details for DOI 10.1038/s44320-025-00140-2

    View details for PubMedID 40931195

    View details for PubMedCentralID 3357908

  • The epigenomic landscape of single vascular cells reflects developmental origin and identifies disease risk loci. bioRxiv : the preprint server for biology Weldy, C. S., Kundu, S., Monteiro, J., Gu, W., Pedroza, A. J., Dalal, A. R., Worssam, M. D., Li, D., Palmisano, B., Zhao, Q., Sharma, D., Nguyen, T., Kundu, R., Fischbein, M. P., Engreitz, J., Kundaje, A. B., Cheng, P. P., Quertermous, T. 2025

    Abstract

    Vascular sites have distinct susceptibility to atherosclerosis and aneurysm, yet the biological underpinning of vascular site-specific disease risk is largely unknown. Vascular tissues have different developmental origins that may influence global chromatin accessibility, and understanding differential chromatin accessibility, gene expression profiles, and gene regulatory networks (GRN) on single cell resolution may give key insight into vascular site-specific disease risk. Here, we performed single cell chromatin accessibility (scATACseq) and gene expression profiling (scRNAseq) of healthy adult mouse vascular tissue from three vascular sites, 1) aortic root and ascending aorta, 2) brachiocephalic and carotid artery, and 3) descending thoracic aorta. Through a comprehensive analysis at single cell resolution, we discovered key regulatory enhancers to not only be cell type, but vascular site specific in vascular smooth muscle (SMC), fibroblasts, and endothelial cells. We identified epigenetic markers of embryonic origin with differential chromatin accessibility of key developmental transcription factors such as Tbx20, Hand2, Gata4, and Hoxb family members and discovered transcription factor motif accessibility to be cell type and vascular site specific. Notably, we found ascending fibroblasts to have distinct epigenomic patterns, highlighting SMAD2/3 function to suggest a differential susceptibility to TGFβ, a finding we confirmed through in vitro culture of primary adventitial fibroblasts. Finally, to understand how vascular site-specific enhancers may regulate human genetic risk for disease, we integrated genome wide association study (GWAS) data for ascending and descending aortic dimension, and through using a distinct base resolution deep learning model to predict variant effect on chromatin accessibility, ChromBPNet, to predict variant effects in SMC, Fibroblasts, and Endothelial cells within ascending aorta, carotid, and descending aorta sites of origin. We reveal that although cell type remains a primary influence on variant effects, vascular site modifies cell type transcription and highlights genomic regions that are enriched for specific TF motif footprints - including MEF2A, SMAD3, and HAND2. This work supports a paradigm that the epigenomic and transcriptomic landscape of vascular cells are cell type and vascular site-specific and that site-specific enhancers govern complex genetic drivers of disease risk.

    View details for DOI 10.1101/2022.05.18.492517

    View details for PubMedID 40655014

    View details for PubMedCentralID PMC12247710

  • Preclinical evaluation of high-resolution CT, 18F-FDG, and 18F-NaF PET imaging for longitudinal monitoring of atherosclerosis. European journal of nuclear medicine and molecular imaging Tamboline, M., Collins, J., Jackson, W., Gu, W., Worssam, M., Cheng, P., David, J., Taschereau, R., Chatziioannou, A. F., Jackson, S., Xu, S., Ikotun, O. F. 2025

    Abstract

    Detection of atherosclerosis is essential to the management and prevention of life-threatening cardiovascular events. Although non-invasive imaging modalities, such as 18F-sodium fluoride (18F-NaF), 18F-fluorodeoxyglucose (18F-FDG) PET, and CT, visualize distinct hallmarks of atherosclerosis, there has yet to be a singular multi-cohort interrogation of their strengths and limitations. Thus, we focused on identifying the optimal approach for visualizing atherosclerosis at different stages of disease progression.In this study, 6-week-old, male, ApoE deficient mice (Apoe-/-) were placed on a high cholesterol diet for 12-20 weeks to induce calcific atherosclerotic disease. Age-matched, male, wildtype (WT) C57BL/6 mice fed with regular chow served as the control group. Mice were imaged at 12, 15, 18, and 20 weeks after starting their respective diets. To follow the progression of calcified atherosclerotic lesions, at each time point, in vivo, 18F-NaF microPET/CT images were acquired 1 h and 3 h post tracer i.v. injection. In a separate cohort, in vivo 18F-FDG PET/CT images were acquired at 3 and 5 h post tracer i.v. injection to follow inflammation as a result of progressive atherosclerotic lesion formation. High-resolution microCT images were acquired for all mice to visualize aorta calcification. After each imaging session, a subset (n = 3) was euthanized from each group and histological analysis of the aorta was performed to confirm disease progression.In this comparative study, within the same cohort, 18F-NaF PET detected atherosclerotic calcification earlier than microCT. At both 1 and 3 h post-injection (p.i.), calcified lesions were clearly detected by 18F-NaF with a six-fold higher signal in Apoe-/- compared to WT mice. Interestingly, 18F-NaF signal peaked at week 18, whereas aortic CT signal progressively increased with a 13-, 16-, and 29-fold at 15, 18, and 20 weeks, respectively. 18F-FDG arortic accumulation at weeks 12 and 15, were significantly greater in Apoe -/- mice than WT control when images were acquired at 5 h but not at 3 h p.i.. In contrast to histological analysis, at ≥ 16 weeks where inflammation is significantly elevated, 18F-FDG was equivalent in Apoe-/- and WT control mice and significantly reduced with disease progression.Our results show that 18F-NaF PET and 18F-FDG PET are sensitive imaging modalities for the early detection of atherosclerotic lesions. However, both 18F-NaF PET and high-resolution microCT prove to be effective methods for monitoring late-stage and progressive disease.

    View details for DOI 10.1007/s00259-025-07276-1

    View details for PubMedID 40289041

    View details for PubMedCentralID 8274865

  • Deciphering the impact of genomic variation on function. Nature 2024; 633 (8028): 47-57

    Abstract

    Our genomes influence nearly every aspect of human biology-from molecular and cellular functions to phenotypes in health and disease. Studying the differences in DNA sequence between individuals (genomic variation) could reveal previously unknown mechanisms of human biology, uncover the basis of genetic predispositions to diseases, and guide the development of new diagnostic tools and therapeutic agents. Yet, understanding how genomic variation alters genome function to influence phenotype has proved challenging. To unlock these insights, we need a systematic and comprehensive catalogue of genome function and the molecular and cellular effects of genomic variants. Towards this goal, the Impact of Genomic Variation on Function (IGVF) Consortium will combine approaches in single-cell mapping, genomic perturbations and predictive modelling to investigate the relationships among genomic variation, genome function and phenotypes. IGVF will create maps across hundreds of cell types and states describing how coding variants alter protein activity, how noncoding variants change the regulation of gene expression, and how such effects connect through gene-regulatory and protein-interaction networks. These experimental data, computational predictions and accompanying standards and pipelines will be integrated into an open resource that will catalyse community efforts to explore how our genomes influence biology and disease across populations.

    View details for DOI 10.1038/s41586-024-07510-0

    View details for PubMedID 39232149

    View details for PubMedCentralID 7405896

  • Network-based prioritization and validation of regulators of vascular smooth muscle cell proliferation in disease. Nature cardiovascular research Lambert, J., Oc, S., Worssam, M. D., Häußler, D., Solomon, C. U., Figg, N. L., Baxter, R., Imaz, M., Taylor, J. C., Foote, K., Finigan, A., Mahbubani, K. T., Webb, T. R., Ye, S., Bennett, M. R., Krüger, A., Spivakov, M., Jørgensen, H. F. 2024; 3 (6): 714-733

    Abstract

    Aberrant vascular smooth muscle cell (VSMC) homeostasis and proliferation characterize vascular diseases causing heart attack and stroke. Here we elucidate molecular determinants governing VSMC proliferation by reconstructing gene regulatory networks from single-cell transcriptomics and epigenetic profiling. We detect widespread activation of enhancers at disease-relevant loci in proliferation-predisposed VSMCs. We compared gene regulatory network rewiring between injury-responsive and nonresponsive VSMCs, which suggested shared transcription factors but differing target loci between VSMC states. Through in silico perturbation analysis, we identified and prioritized previously unrecognized regulators of proliferation, including RUNX1 and TIMP1. Moreover, we showed that the pioneer transcription factor RUNX1 increased VSMC responsiveness and that TIMP1 feeds back to promote VSMC proliferation through CD74-mediated STAT3 signaling. Both RUNX1 and the TIMP1-CD74 axis were expressed in human VSMCs, showing low levels in normal arteries and increased expression in disease, suggesting clinical relevance and potential as vascular disease targets.

    View details for DOI 10.1038/s44161-024-00474-4

    View details for PubMedID 38898928

    View details for PubMedCentralID PMC11182749

  • Network-based prioritization and validation of regulators of vascular smooth muscle cell proliferation in disease. Nature cardiovascular research Lambert, J., Oc, S., Worssam, M. D., Häußler, D., Solomon, C. U., Figg, N. L., Baxter, R., Imaz, M., Taylor, J. C., Foote, K., Finigan, A., Mahbubani, K. T., Webb, T. R., Ye, S., Bennett, M. R., Krüger, A., Spivakov, M., Jørgensen, H. F. 2024; 3 (6): 714-733

    Abstract

    Aberrant vascular smooth muscle cell (VSMC) homeostasis and proliferation characterize vascular diseases causing heart attack and stroke. Here we elucidate molecular determinants governing VSMC proliferation by reconstructing gene regulatory networks from single-cell transcriptomics and epigenetic profiling. We detect widespread activation of enhancers at disease-relevant loci in proliferation-predisposed VSMCs. We compared gene regulatory network rewiring between injury-responsive and nonresponsive VSMCs, which suggested shared transcription factors but differing target loci between VSMC states. Through in silico perturbation analysis, we identified and prioritized previously unrecognized regulators of proliferation, including RUNX1 and TIMP1. Moreover, we showed that the pioneer transcription factor RUNX1 increased VSMC responsiveness and that TIMP1 feeds back to promote VSMC proliferation through CD74-mediated STAT3 signaling. Both RUNX1 and the TIMP1-CD74 axis were expressed in human VSMCs, showing low levels in normal arteries and increased expression in disease, suggesting clinical relevance and potential as vascular disease targets.

    View details for DOI 10.1038/s44161-024-00474-4

    View details for PubMedID 39215134

    View details for PubMedCentralID 8260472

  • Genome-Wide Genetic Associations Prioritize Evaluation of Causal Mechanisms of Atherosclerotic Disease Risk. Arteriosclerosis, thrombosis, and vascular biology Quertermous, T., Li, D. Y., Weldy, C. S., Ramste, M., Sharma, D., Monteiro, J. P., Gu, W., Worssam, M. D., Palmisano, B. T., Park, C. Y., Cheng, P. 2024; 44 (2): 323-327

    Abstract

    The goal of this review is to discuss the implementation of genome-wide association studies to identify causal mechanisms of vascular disease risk.The history of genome-wide association studies is described, the use of imputation and the creation of consortia to conduct meta-analyses with sufficient power to arrive at consistent associated loci for vascular disease. Genomic methods are described that allow the identification of causal variants and causal genes and how they impact the disease process. The power of single-cell analyses to promote genome-wide association studies of causal gene function is described.Genome-wide association studies represent a paradigm shift in the study of cardiovascular disease, providing identification of genes, cellular phenotypes, and disease pathways that empower the future of targeted drug development.

    View details for DOI 10.1161/ATVBAHA.123.319480

    View details for PubMedID 38266112

  • Comprehensive Integration of Multiple Single-Cell Transcriptomic Datasets Defines Distinct Cell Populations and Their Phenotypic Changes in Murine Atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology Sharma, D., DeForest Worssam, M., Pedroza, A. J., Dalal, A. R., Alemany, H., Kim, H. J., Kundu, R., Fischbein, M., Cheng, P., Wirka, R., Quertermous, T. 2023

    Abstract

    The application of single-cell transcriptomic (single-cell RNA sequencing) analysis to the study of atherosclerosis has provided unique insights into the molecular and genetic mechanisms that mediate disease risk and pathophysiology. However, nonstandardized methodologies and relatively high costs associated with the technique have limited the size and replication of existing data sets and created disparate or contradictory findings that have fostered misunderstanding and controversy.To address these uncertainties, we have performed a conservative integration of multiple published single-cell RNA sequencing data sets into a single meta-analysis, performed extended analysis of native resident vascular cells, and used in situ hybridization to map the disease anatomic location of the identified cluster cells. To investigate the transdifferentiation of smooth muscle cells to macrophage phenotype, we have developed a classifying algorithm based on the quantification of reporter transgene expression.The reporter gene expression tool indicates that within the experimental limits of the examined studies, transdifferentiation of smooth muscle cell to the macrophage lineage is extremely rare. Validated transition smooth muscle cell phenotypes were defined by clustering, and the location of these cells was mapped to lesion anatomy with in situ hybridization. We have also characterized 5 endothelial cell phenotypes and linked these cellular species to different vascular structures and functions. Finally, we have identified a transcriptomically unique cellular phenotype that constitutes the aortic valve.Taken together, these analyses resolve a number of outstanding issues related to differing results reported with vascular disease single-cell RNA sequencing studies, and significantly extend our understanding of the role of resident vascular cells in anatomy and disease.

    View details for DOI 10.1161/ATVBAHA.123.320030

    View details for PubMedID 38152886

  • Cellular mechanisms of oligoclonal vascular smooth muscle cell expansion in cardiovascular disease CARDIOVASCULAR RESEARCH Worssam, M. D., Lambert, J., Oc, S., Taylor, J. C. K., Taylor, A. L., Dobnikar, L., Chappell, J., Harman, J. L., Figg, N. L., Finigan, A., Foote, K., Uryga, A. K., Bennett, M. R., Spivakov, M., Jorgensen, H. F. 2023; 119 (5): 1279-1294

    Abstract

    Quiescent, differentiated adult vascular smooth muscle cells (VSMCs) can be induced to proliferate and switch phenotype. Such plasticity underlies blood vessel homeostasis and contributes to vascular disease development. Oligoclonal VSMC contribution is a hallmark of end-stage vascular disease. Here, we aim to understand cellular mechanisms underpinning generation of this VSMC oligoclonality.We investigate the dynamics of VSMC clone formation using confocal microscopy and single-cell transcriptomics in VSMC-lineage-traced animal models. We find that activation of medial VSMC proliferation occurs at low frequency after vascular injury and that only a subset of expanding clones migrate, which together drives formation of oligoclonal neointimal lesions. VSMC contribution in small atherosclerotic lesions is typically from one or two clones, similar to observations in mature lesions. Low frequency (<0.1%) of clonal VSMC proliferation is also observed in vitro. Single-cell RNA-sequencing revealed progressive cell state changes across a contiguous VSMC population at onset of injury-induced proliferation. Proliferating VSMCs mapped selectively to one of two distinct trajectories and were associated with cells showing extensive phenotypic switching. A proliferation-associated transitory state shared pronounced similarities with atypical SCA1+ VSMCs from uninjured mouse arteries and VSMCs in healthy human aorta. We show functionally that clonal expansion of SCA1+ VSMCs from healthy arteries occurs at higher rate and frequency compared with SCA1- cells.Our data suggest that activation of proliferation at low frequency is a general, cell-intrinsic feature of VSMCs. We show that rare VSMCs in healthy arteries display VSMC phenotypic switching akin to that observed in pathological vessel remodelling and that this is a conserved feature of mouse and human healthy arteries. The increased proliferation of modulated VSMCs from healthy arteries suggests that these cells respond more readily to disease-inducing cues and could drive oligoclonal VSMC expansion.

    View details for DOI 10.1093/cvr/cvac138

    View details for Web of Science ID 000853175400001

    View details for PubMedID 35994249

    View details for PubMedCentralID PMC10202649

  • The epigenomic landscape of single vascular cells reflects developmental origin and identifies disease risk loci bioRxiv Weldy, C. S., Cheng, P. P., Pedroza, A. J., Dalal, A. R., Sharma, D., Kim, H., Shi, H., Nguyen, T., Kundu, R. K., Fischbein, M. P., Quertermous, T. 2022
  • Mechanisms of vascular smooth muscle cell investment and phenotypic diversification in vascular diseases BIOCHEMICAL SOCIETY TRANSACTIONS Worssam, D., Jorgensen, F. 2021; 49 (5): 2101-2111

    Abstract

    In contrast with the heart, the adult mammalian vasculature retains significant remodelling capacity, dysregulation of which is implicated in disease development. In particular, vascular smooth muscle cells (VSMCs) play major roles in the pathological vascular remodelling characteristic of atherosclerosis, restenosis, aneurysm and pulmonary arterial hypertension. Clonal lineage tracing revealed that the VSMC-contribution to disease results from the hyperproliferation of few pre-existing medial cells and suggested that VSMC-derived cells from the same clone can adopt diverse phenotypes. Studies harnessing the powerful combination of lineage tracing and single-cell transcriptomics have delineated the substantial diversity of VSMC-derived cells in vascular lesions, which are proposed to have both beneficial and detrimental effects on disease severity. Computational analyses further suggest that the pathway from contractile VSMCs in healthy arteries to phenotypically distinct lesional cells consists of multiple, potentially regulatable, steps. A better understanding of how individual steps are controlled could reveal effective therapeutic strategies to minimise VSMC functions that drive pathology whilst maintaining or enhancing their beneficial roles. Here we review current knowledge of VSMC plasticity and highlight important questions that should be addressed to understand how specific stages of VSMC investment and phenotypic diversification are controlled. Implications for developing therapeutic strategies in pathological vascular remodelling are discussed and we explore how cutting-edge approaches could be used to elucidate the molecular mechanisms underlying VSMC regulation.

    View details for DOI 10.1042/BST20210138

    View details for Web of Science ID 000697466600001

    View details for PubMedID 34495326

    View details for PubMedCentralID PMC8589433

  • VSMC CONTRIBUTION TO NEOINTIMAL LESIONS ARISES FROM THE CLONAL EXPANSION OF FEW PRIMED CELLS Worssam, M. BMJ PUBLISHING GROUP. 2021: A173
  • Epigenetic Regulation of Vascular Smooth Muscle Cells by Histone H3 Lysine 9 Dimethylation Attenuates Target Gene-Induction by Inflammatory Signaling ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY Harman, J. L., Dobnikar, L., Chappell, J., Stokell, B. G., Dalby, A., Foote, K., Finigan, A., Freire-Pritchett, P., Taylor, A. L., Worssam, M. D., Madsen, R. R., Loche, E., Uryga, A., Bennett, M. R., Jorgensen, H. F. 2019; 39 (11): 2289-2302

    Abstract

    Vascular inflammation underlies cardiovascular disease. Vascular smooth muscle cells (VSMCs) upregulate selective genes, including MMPs (matrix metalloproteinases) and proinflammatory cytokines upon local inflammation, which directly contribute to vascular disease and adverse clinical outcome. Identification of factors controlling VSMC responses to inflammation is therefore of considerable therapeutic importance. Here, we determine the role of Histone H3 lysine 9 di-methylation (H3K9me2), a repressive epigenetic mark that is reduced in atherosclerotic lesions, in regulating the VSMC inflammatory response. Approach and Results: We used VSMC-lineage tracing to reveal reduced H3K9me2 levels in VSMCs of arteries after injury and in atherosclerotic lesions compared with control vessels. Intriguingly, chromatin immunoprecipitation showed H3K9me2 enrichment at a subset of inflammation-responsive gene promoters, including MMP3, MMP9, MMP12, and IL6, in mouse and human VSMCs. Inhibition of G9A/GLP (G9A-like protein), the primary enzymes responsible for H3K9me2, significantly potentiated inflammation-induced gene induction in vitro and in vivo without altering NFκB (nuclear factor kappa-light-chain-enhancer of activated B cell) and MAPK (mitogen-activated protein kinase) signaling. Rather, reduced G9A/GLP activity enhanced inflammation-induced binding of transcription factors NFκB-p65 and cJUN to H3K9me2 target gene promoters MMP3 and IL6. Taken together, these results suggest that promoter-associated H3K9me2 directly attenuates the induction of target genes in response to inflammation in human VSMCs.This study implicates H3K9me2 in regulating the proinflammatory VSMC phenotype. Our findings suggest that reduced H3K9me2 in disease enhance binding of NFκB and AP-1 (activator protein-1) transcription factors at specific inflammation-responsive genes to augment proinflammatory stimuli in VSMC. Therefore, H3K9me2-regulation could be targeted clinically to limit expression of MMPs and IL6, which are induced in vascular disease.

    View details for DOI 10.1161/ATVBAHA.119.312765

    View details for Web of Science ID 000494483700016

    View details for PubMedID 31434493

    View details for PubMedCentralID PMC6818986